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The majority of the effects of cyclosporin A (CsA) on
cells is caused by the inhibition of phosphatase activity
of calcineurin (CN) by the cyclophilin A (CyPA)-CsA
complex formed in the cytoplasm. Although CsA inhibits
the proliferation of a large number of parasites, not all
are susceptible. The presence of structurally altered
CyPA with lower affinity for CsA had been suggested to
be the cause of resistance. We report here the identifi-
cation and cloning of a high affinity CsA-binding protein
(LdCyP) from Leishmania donovani, a trypanosomatid
parasite that is naturally resistant to CsA. The trans-
lated LdCyP consists of 187 amino acids with a cleavable
21-amino acid hydrophobic NH2-terminal extension.
Modeling studies confirmed that all the residues of hu-
man CyPs responsible for interaction with CsA are se-
quentially and conformationally conserved in LdCyP.
The purified recombinant protein displayed biochemi-
cal parameters comparable to human CyPs. Reverse
transcription-polymerase chain reaction analysis con-
firmed that LdCyP was abundantly expressed. Immuno-
blot experiments and direct CsA binding studies re-
vealed that LdCyP located in the subcellular organelles
constituted the bulk of the CsA binding activity present
in L. donovani, whereas the level of binding activity in
the cytosol was conspicuously low. CsA selectively facil-
itated the secretion of LdCyP in the culture medium.
Based on these results, it is concluded that the insensi-
tivity of L. donovani to CsA is probably due to the pau-
city of CsA binding activity in the cytoplasm of the par-
asite. We suggest that LdCyP, located in the secretory
pathway, may function as a chaperone by binding to
membrane proteins rather than as the mediator of CN
inhibition.
Studies on mechanisms of drug action and drug resistance
have often led to the discovery of new biological phenomena.
Cyclosporin A (CsA),1 a lipophilic cyclic undecapeptide, was
originally discovered as an antifungal agent (1). Its diverse
effects on various cells, which range from immunosuppression
to inhibition of cell proliferation, have kindled great interest in
the studies related to its mode of action. Most, if not all, of the
effects of CsA are exerted through the formation of a specific
complex with cyclophilins (CyPs), a multigenic family of pro-
teins. The CyPzCsA complex formed in the cytoplasm binds to
calcineurin and inhibits its serine-threonine protein phospha-
tase activity, which leads to immunosuppression (2). The for-
mation of such a binary complex between CyP and CsA is thus
the first crucial step for CsA action.
Of the five isoforms of CyPs (CyPA, CyPB, CyPC, CyPD, and
CyP40) that have been identified in mammalian tissues, CyPA
and CyPB are well studied (3–5). All CyPs are known to exhibit
CsA-sensitive peptidylprolyl cis-trans isomerase activity; how-
ever, the inhibition of peptidylprolyl cis-trans isomerase activ-
ity is unrelated to immunosuppression. Due to their multiple
cellular localization, this group of proteins exhibits other bio-
logical functions such as signal transduction, protein-protein
interaction, protein folding, and several cellular processes be-
sides immunosuppression (6–9). CyPA, the most abundant and
ubiquitously expressed cytosolic CsA-binding protein, is known
to play a direct role in CsA-mediated inhibition of immune
function and cell proliferation (2). In contrast, CyPB located in
the secretory pathway plays the role of chaperone to proteins
destined for plasma membranes (9, 10). A dual localization of
CyP encoded by the same gene has been found both in the
cytosol and mitochondria of Neurospora crassa (11).
Leishmania donovani, a dimorphic parasitic protozoan, is
the causative agent of kala azar in humans. This protozoan
exists as a flagellated promastigote (extracellular form) in the
sand fly vector and is transformed into amastigote (intracellu-
lar form) in the mammalian macrophages. CsA has a wide
range of effects on various parasitic protozoa both in vivo and
in vitro (12). Despite the fact that CsA is highly toxic to many
parasites viz. Plasmodium, Schistosoma, tapeworms, and Tox-
oplasma gondii, there are others that are insensitive to this
drug (13). The cause of resistance in some of these parasites
has been attributed to the absence of the concensus CsA bind-
ing motif in their CyPs. Despite normal uptake of the drug, the
in vivo and in vitro effects of CsA on various Leishmania
parasites are conflicting. Cutaneous lesions in susceptible mice
caused by infection of Leishmania major or Leishmania tropica
could be prevented with the administration of CsA or its non-
immunosuppressive analogs. In contrast, CsA distinctly exac-
erbated intracellular L. donovani (amastigote) parasite load in
murine cells, suggesting possible differences in the status of
CyPs in these two species of Leishmania (13).
Rascher et al. (14) suggest that due to the occurrence of a
single amino acid change (Arg 3 Asn with respect to Arg69 of
human CyPA) in the CyP of L. major, the CyPzCsA complex
fails to interact with the calcineurin (CN) in the cell. In con-
trast, both T. gondii and Plasmodium falciparum are known to
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harbor Asn in the same position of their cytosolic CyPs, yet
they are highly sensitive to the drug (15, 16). This raises the
question of the importance of this particular Arg residue in CN
binding. Moreover, the recent report that the CN-associated
serine-threonine phosphatase activity present in the whole cell
extract of L. donovani can be effectively inhibited in vitro by the
sole addition of exogenous CsA suggests that CsA resistance in L.
donovani probably occurs by an alternative mechanism (17).
In an effort to understand the mechanism by which L. dono-
vani becomes resistant to CsA, we set out to analyze the status
of CyPs in this organism. This article deals with identification,
sequencing, structural analysis, and expression of a CyP ho-
mologue distinctly different from that reported in L. major. Our
results show that L. donovani lacks a threshold level of high
affinity CsA-binding protein (CyPA) in the cytosol. The obser-
vation that L. donovani is deficient in cytosolic CyP is novel
and provides a potential explanation for CsA resistance of the
parasite, supporting the growing notion that a balance in the
concentrations of cytoplasmic immunophilins and CN play an
important role in determining the effectiveness of immunosup-
pressants. A possible biological role of this CyP in L. donovani
is also suggested.
MATERIALS AND METHODS
Reagents, Cells, and Libraries—All chemicals used were of analytical
grade. L. donovani promastigote (D1700), a clone of Sudanese 1S strain
and its genomic library made in bacteriophage lGEM-11, were kindly
provided by Prof. Buddy Ullman (18). Cells were grown at 26 °C under
mild shaking in Dulbecco’s modified Eagle’s medium (Life Technologies,
Inc.) supplemented with fetal calf serum (10%), hemin (5 mg/liter),
xanthine (0.1 mM), 0.3% bovine serum albumin fraction V (Sigma),
biotin (1 mg/liter), and Tween 80 (40 mg/liter) along with NaHCO3
(3.7gm/liter) and 20 mM Hepes, pH 7.3. Exponentially grown cells were
used in all experiments. [3H]CsA (7Ci/mmol) was purchased from Am-
ersham Pharmacia Biotech. CsA and D-Ala(3-amino)8-CsA were gifts
from Drs. G. Engel and B. P. Richardson respectively of Sandoz Phar-
maceuticals, Basel, Switzerland.
Isolation of LdCyP-encoding Sequence—Filters containing 150,000
plaques of an L. donovani genomic DNA library constructed in
lGEM-11 bacteriophage were screened with 32P-labeled degenerate
antisense oligonucleotide (59-GGATCCRAAIACIACRTGICGICCRTC-
39) synthesized from the most conserved part (DGRHVVF) of the CsA
binding sequence (WLDGRHVVF) found in most CyPs from a variety of
sources. Hybridization was carried out in 63 SSC (13 SSC 5 0.15 M
NaCl and 0.015 M sodium citrate) buffer at 40 °C overnight according to
standard published protocol. After washing in 63 SSC, 0.1% SDS at
room temperature, filters were autoradiographed. DNA isolated from
six positive plaques were cleaved with PstI-XhoI and Southern-hybrid-
ized with the same oligonucleotide. An ;4.2-kilobase hybridized band
was eluted from a duplicate gel and ligated into the pBS vector. Auto-
mated DNA sequencing was carried out, and the analysis of the se-
quence was done using DNASIS program.
Characterization of the LdCyP Transcript —Total RNA was prepared
according to the procedure published elsewhere (18). The integrity of
the RNA was checked by undegraded ribosomal RNA bands on
ethidium bromide-stained gels. To detect and characterize the LdCyP
transcript in Leishmania, the following reaction was carried out: initial
reverse transcription reaction (25 ml) contained total RNA (1 mg), 2.5
pmol of oligo(dT)18, 200 mM dNTPs, 5 mM DTT, 5 units of RNasin, 1.5 mM
MgCl2, 5% (v/v) Me2SO, and 1 ml of enzyme (Titan
TM). The reaction was
carried out at 37 °C for 5 min followed by 1 h at 42 °C. To amplify the
LdCyP-specific cDNA, 20 pmol each of the sense primer, 59-CTCGGAAT-
TCCAACGCTATATAAGTATCAGTTTCTGTACTTTATTG-39, containing
a short leader sequence with an EcoRI site followed by 36 of the 39-
nucleotide mini-exon (19), and an antisense primer, 59-GCCGAAAACCA-
CATGGCGG-39 (438–456), designed from a part (GRHVVFG) of the con-
served CsA binding motif (WLDGRHVVFG), were added to the reverse
transcription mixture. The PCR reaction was continued for 35 cycles at
94, 55, and 68 °C for 1, 1, and 2 min, respectively. Products were sepa-
rated on 1.2% agarose gel, probed with a reverse internal oligonucleotide,
59-GCCGCCCTGGATCATGAAG-39 (247–265), designed from the peptide
sequence 83FMIQGG88 (to confirm the product), and subcloned into pBS
vector at EcoRI/SmaI sites, and sequenced.
Expression and Purification of Recombinant LdCyP—The coding se-
quence (amino acid 22–187) without the 21-amino acid amino-terminal
signal sequence was amplified by PCR and ligated in-frame at the
NdeI/BamHI sites of pET3a expression plasmid (Stratagene). The 59-
PCR primer (sense), 59- CTCGAATTCATATGGAGCCGGAGGTGACC-
GCG-39 with an NdeI site and 39-primer (antisense), 59- CGACCAGG-
ATCCCTACAGCTCACCACTGGCA-39 containing a BamHI site were
used. The PCR product, after digestion with NdeI/BamHI, was cloned in
pET3a and transformed into Escherichia coli BL21(DE3)pLysS cells.
The cells containing the chimeric plasmid were induced with isopropyl-
1-thio-b-D-galactopyranoside (1 mM) at 37 °C for 4–8 h, and induced
protein (molecular mass 17.7 kDa) was purified following a published
procedure (20). Using a similar strategy, another expression plasmid
was constructed by ligating the same insert (coding amino acid 22–187)
at the BamHI/SalI sites of the expression vector pQE32 (Qiagen),
resulting in isopropyl-1-thio-b-D-galactopyranoside-inducible expres-
sion of the LdCyP as a histidine-tagged fusion protein. LdCyP from E.
coli M15 cells harboring the plasmid was purified to homogeneity using
a nickel-nitrilotriacetic acid-agarose column as per the manufacturer’s
suggested procedure. For all the biochemical experiments, imidazole-
eluted His-tagged LdCyP that was extensively dialyzed against a buffer
containing 10 mM Tris, pH 7.5, and 0.1 mM DTT was used.
Peptidylprolyl cis-trans Isomerase and CsA Binding Assays—Pepti-
dylprolyl cis-trans isomerase activity in the purified recombinant
LdCyP was measured using a synthetic tetrapeptide substrate N-suc-
cinyl-AAPF-p-nitroanilide. The procedure of assay and calculations was
essentially the same as described by Kofron et al. (21). For CsA binding
studies, both Sephadex LH-20 column assay using 3HCsA (7Ci/mmol)
and fluorescence enhancement assay of CyPs, caused due to binding of
CsA, were used (22, 23).
Antisera Production and Immunoblotting—Polyclonal rabbit anti-
sera against SDS-polyacrylamide gel electrophoresis-purified recombi-
nant LdCyP, was raised, and immunoblotting of the sample was carried
out using 125I-labeled protein A as the secondary ligand (24).
Isoelectric Focussing—The sample for isoelectric focussing was made
by mixing the total extract with 33 buffer (30% glycerol, 10% ampho-
lines, pH 3.5–10). Tube gel was prepared using 4% acrylamide and 2%
ampholine. Electrophoresis was carried out for 3 h at 200 volts using
0.01 M NaOH and 0.02 M orthophosphoric acid at the anode and cathode,
respectively. After the first-dimension run, the tube was placed hori-
zontally on a SDS-polyacrylamide slab gel, and electrophoresis was
carried out.
Preparation of Whole Cell Extract and Subcellular Fractions—For
the preparation of whole parasite extract, cells were directly suspended
in buffer (50 mM Tris-HCl, pH 7.5, 150 mM KCl, 1 mM EDTA, 1 mM
phenylmethylsulfonyl fluoride, 1 mM DTT, and 10 mg/ml each leupeptin
and aprotinin) containing 0.5% CHAPS. The sample was sonicated and
clarified by centrifugation at 10,000 3 g for 30 min. For cellular sub-
fractionation, the procedures of High et al. (15) and Harris et al. (25)
were essentially followed. Briefly, the cells were harvested and washed
with ice-cold buffer (150 mM NaCl, 20 mM glucose, 20 mM Na2HPO4, 1.8
mM KH2PO4, adjusted to pH 7.4 with HCl). The washed cell pellet was
suspended at 1.2 3 109 cells/ml in 1 mM Tris-HCl, pH 8.0, 1 mM EDTA,
briefly homogenized in a Dounce homogenizer, and gently lysed by
passing through a 26-gauge needle. Sucrose (60%) was immediately
added to a final concentration of 0.25 M. The mixture was centrifuged at
100,000 3 g for 2 h. The resultant supernatant was called the ”cytosol
fraction.“ The pellet, containing mostly different organelles and mem-
branes, referred to as ”particulate fraction,“ was suspended in 0.5%
CHAPS-containing buffer, sonicated, and dialyzed extensively against
buffer containing 20 mM Tris-HCl, pH 7.5, 1 mM EDTA,100 mM NaCl, 1
mM phenylmethylsulfonyl fluoride, and 1 mM DTT.
Amino-terminal Sequencing of CsA Binding Proteins—For amino-
terminal sequencing, the CsA-binding proteins were enriched from
different sources using CsA analog (D-Ala(3-amino)8-CsA) affinity col-
umn as per the published procedure (26). In brief, the extracts from
different sources (rat liver or different subcellular fractions of the
parasite) were loaded onto the column. After extensive washing of the
column with buffer (20 mM Tris-HCl, pH7.5, 1 mM EDTA, and 100 mM
NaCl), the bound proteins were eluted with the same buffer containing
10 mg/ml CsA. The eluate containing CsA-binding proteins was pooled
and precipitated with trichloroacetic acid, separated by SDS-polyacryl-
amide gel electrophoresis, transferred to a polyvinylidene difluoride
membrane, and immunoblotted using LdCyP antibodies. Immunoposi-
tive protein bands from a duplicate polyvinylidene difluoride paper
were cut out and subjected to amino-terminal sequencing.
Modeling Studies—Modeling was performed on an Indigo II silicon
graphics work station using human CyPA as the template (27–30).
Several rounds of energy minimization using the CHARM force field
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parameters in X-PLOR coupled with local manual model building using
FRODO was performed (31, 32). The final model was superposed onto
human CyPA in its complex structure with CsA and subjected to addi-
tional cycles of energy minimization (33).
LdCyP Secretion Experiment—Exponentially grown L. donovani
(D1700) promastigotes were harvested and washed twice with Dulbec-
co’s modified Eagle’s medium depleted of fetal bovine serum and bovine
serum albumin as described before. The cell pellet was then suspended
in the same medium at a density of 107cells/ml and divided into three
equal parts. One part was allowed to grow as such, whereas another
was grown in the presence of noninhibitory concentrations of CsA (2
mM). To the third part, sodium azide (50 mM) was included along with
CsA. Growth was continued at 22 °C for 24 h. At the indicated times, a
measured aliquot of the cell suspension from each of the three cultures
were withdrawn and harvested. The cell pellets obtained were boiled in
SDS-mercaptoethanol containing buffer (cell extract). The spent media
from each culture after passing through GF/C filters were dialyzed
against buffer (10 mM Tris, pH 7.5, 1 mM phenylmethylsulfonyl fluoride,
and 1 mM DTT) and concentrated. Cell extracts and the corresponding
processed media were subjected to Western blot analysis using LdCyP
antisera.
RESULTS
Sequence Analysis of LdCyP—Screening of an L. donovani
(D1700) genomic library made in bacteriophage lGEM-11 with
a degenerate oligonucleotide, based on a highly conserved
amino acid sequence, led to the isolation of six positive chimeric
phage clones. Sequencing of a portion (a 4.2-kilobase PstI/XhoI
fragment) of the insert from all six phage clones and transla-
tion of the sequences in all possible reading frames predicted
the presence of an open reading frame consisting of 187 amino
acids, corresponding to a polypeptide of 20,643 daltons (Fig. 1).
A 159-amino acid stretch of this encoding sequence (spanning
amino acids 22–181) of LdCyP showed 67% homology with
human CyPB (Fig. 2). Several of the sequence stretches found
in CyPs from other sources, viz. the consensus CsA-docking site
[WLDG(K or R)HVVFG] and sequences like SMANAG and
FM(C/I)QGGDF, were also present in the LdCyP sequence (Fig.
2). Primary structure analysis of LdCyP and its modeling re-
vealed that the entire set of 13 residues in human CyPA known
to interact with CsA are sequentially and conformationally
conserved in LdCyP, making it quite capable of equivalent
interactions with the ligand molecule (Figs. 2 and 3) (1). The
root mean square deviation between their Ca atoms was calcu-
lated to be 0.85 Å. The three charged residues (Arg69, Lys125,
and Arg148) of human CyPA implicated in the electronic inter-
action with CN were, however, replaced in the LdCyP by Asn,
Arg, and Asn, respectively (Fig. 2). It is to be mentioned here
that the complex of CsA with human CyPB, which harbors Arg,
Lys, and Asp in positions corresponding to Arg69, Lys125, and
Arg148 of CyPA, is 14-fold more effective as a CN inhibitor than
the CyPAzCsA complex (34). Furthermore T. gondii and P.
falciparum, despite having Asn, Lys, Ser and Asn, Lys, Lys in
the corresponding positions of their cytosolic isoforms, are
highly sensitive to CsA in vivo (15, 16). Therefore, factors other
than these three amino acids of CyPs are probably responsible
for the differential affinity of these molecules with CN (34). The
PSIGNAL program of the PCGENE sequence analysis software
package further predicted that the encoded LdCyP contained a
typical endoplasmic reticulum-directed signal sequence at the
amino-terminal end of the protein, with the predicted cleavage
occurring between the amino acids 21 and 22 (35).
Biochemical Characterization of LdCyP—The purified re-
combinant 63His-LdCyP without the signal sequence cata-
lyzed the isomerization of the prolyl-peptide bond in the syn-
thetic substrate with a Kcat/Km of 6.3 3 10
6 M21s21 at 10 °C.
The activity was drastically inhibited at a nearly 1:1 molar
ratio of 63His-LdCyP to CsA (Fig. 4A). Binding of CsA to
recombinant 63His-LdCyP, as determined by a fluorescence
enhancement assay, followed a typical saturation kinetics (Fig.
4B). From the Scatchard analysis, the stoichiometry of associa-
tion was determined to be 1:1 with a Kd of 135 nM (Fig. 4B, inset).
These values are close to the published values for CyPs isolated
and characterized from various other sources (9, 20, 22).
Characterization of the LdCyP Transcript in L. donovani Pro-
mastigotes—To ascertain the level of expression of LdCyP gene,
Northern blot analysis was carried out with total promastigote
RNA. However, even with .30 mg of RNA and a very high
specific activity randomly labeled LdCyP gene probe, the tran-
script signal was barely visible. Thus, to characterize the tran-
script, an RT-PCR approach was adapted. Due to the phenome-
non of transplicing in Leishmania, the 59 termini of all mature
mRNAs are known to contain an identical 39-nucleotide-long
mini-exon sequence (19). It was therefore reasoned that the use
of this common mini-exon sequence as a sense primer along with
the antisense internal oligonucleotide primer designed from the
conserved CsA binding region (WLDGRHVVFG) should amplify
at least one (LdCyP) if not all of the isoforms of the CyP gene
family present in the total RNA. A Southern blot of the RT-PCR
reaction products probed with an oligonucleotide designed
against another conserved internal sequence (83FMIQGG88) de-
tected only one hybridizable band (Fig. 5b). Cloning and sequenc-
ing of the RT-PCR product revealed a 713-base pair cDNA that
originated from transcription of the cognate LdCyP gene. The
mini-exon was transpliced at 2221 base pairs upstream of the
predicted translation initiation site (Fig. 1). These results clearly
indicated that in Leishmania promastigotes, LdCyP gene, along
with its hydrophobic amino-terminal extension, was indeed tran-
scribed to certain abundance to be analyzed by RT-PCR, whereas
the other CyP transcripts (if at all present) could not be detected
under this condition.
Subcellular Distribution of LdCyP—The failure to detect other
isoforms of CyP transcripts in the free-living L. donovani could be
due to (a) the paucity of respective concentrations of transcripts,
FIG. 1. Nucleotide and deduced amino acid sequence of
LdCyP. The solid underline indicates the signal peptide-like sequence.
The down arrow (2) shows the predicted site for signal-peptide cleav-
age. The closed box represents the sequence homologous to CyPs from
other sources, and the symbol () indicates the site of transplicing of the
mini-exon.
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(b) the use of LdCyP-specific reverse primer rather than its
degenerate form in both RT-PCR and southern hybridization, or
(c) analysis of fewer clones generated from the RT-PCR reaction
product. To sort this out and to determine the number of different
CyP proteins expressed in Leishmania, immunoblot analysis of
the whole parasite extract and its different subcellular fractions
was carried out using polyclonal antisera raised against SDS-
polyacrylamide gel electrophoresis-purified recombinant LdCyP.
Due to extensive amino acid homology, the antigenic cross-
reactivity among different CyP isoforms within the same species
and across different species is well established (3, 36, 37). This
was confirmed by cross-reactivity of the LdCyP antisera with
several of the well characterized CyP isoforms (CyPA, CyPB, and
CyP40) from rat liver, cytosolic recombinant CyP from P. falcip-
arum (PfCyP19) (Fig. 6A), and even with E. coli CyP (data not
shown). Western blot analysis of different subcellular fractions of
L. donovani revealed that the immunoreactive protein detected
in the total extract was mostly sequestered in the particulate
fraction of the cell (Fig. 6B, upper panel). Contrastingly, the
cytosol fraction did not display any additional band except the
one seen in other two extracts. The faint band observed in the
cytosol fraction was clearly due to leaching of the same protein
from the particulate fraction. Futhermore, the immunoreactive
protein in all of the fractions appeared to be equal in size to that
of the recombinant LdCyP (Mr 17.7 kDa) that lacked the putative
signal sequence (Fig. 6B, upper panel). A control immunoblot of
FIG. 2. Comparison of the predicted
amino acid sequence of LdCyP with
CyPs from L. major (L.m) (14), human
(Hu.A and Hu.B) (3, 9), P. falciparum
(P.f19) (16), and Brugia malayi (B.m)
(53). The sequences were aligned by
CLUSTAL W (54). Dashed lines were in-
troduced to achieve maximum homology.
Amino acid residues predicted to be in-
volved in CsA binding and calcineurin
docking are represented by asterisks (*)
and number signs (#), respectively. Dark
boxes represent sequences found in most
CyPs, whereas the large open box repre-
sents the conserved sequence against
which the internal oligonucleotide was
designed. L.d, L. donovani.
FIG. 3. Ribbon diagram of LdCyP. Modeled LdCyP (red) was su-
perposed on human CyPA (blue) CsA (ball and stick) complex. Arg148 of
human CyPA is shown on the top left-hand side of the figure, indicated
by an arrow.
FIG. 4. Biochemical characterization of recombinant LdCyP.
A, progress curves from the chymotrypsin-coupled assay for 63His-
LdCyP peptidylprolyl cis-trans isomerase. Shown are nonenzymatic
isomerization without 63His-LdCyP (a), 7.8 nM 63His-LdCyP (b), 11.8
nM 63His-LdCyP (c), and 11.8 nM 63His-LdCyP plus 300 nM CsA (d). B,
Binding of CsA to 63His-LdCyP using fluorescence enhancement as-
say. To recombinant 63His-LdCyP (247 nM) increasing concentrations
of CsA was added, and the change in absolute fluorescence was moni-
tored. The inset shows a Scatchard analysis of binding.
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all the fractions with antibodies to L. donovani-specific adenosine
kinase, an enzyme known to be present exclusively in the cytosol
of L. donovani, confirmed that the particulate fraction was free of
unlysed cells and cytosolic proteins (Fig. 6B, lower panel) (24, 38).
The immunoblot of a two-dimension-run gel with total CHAPS
extract further confirmed that the 17.7-kDa band was indeed due
to a single immunoreactive protein (Fig. 6C). It is to be noted that
the molecular mass of the immunoreactive protein (17.7 kDa)
detected in both total extract and the particulate fraction is
significantly smaller (by ;2.9 kDa) than the size predicted from
the open reading frame (20.6 kDa). To confirm that the 17.7-kDa
protein was indeed the bona fide LdCyP gene product, extracts
from all three fractions (total, cytosolic, and particulate) were
passed through a CsA analog affinity column. Bound proteins,
after elution with buffer containing CsA, were resolved on SDS-
polyacrylamide gel electrophoresis (in duplicate). One of the gels
was subjected to immunoblotting with LdCyP antisera, whereas
the other gel was processed for NH2-terminal sequencing. Ex-
pectedly, the CsA column eluate of the cytosol extract failed to
react on the Western blot. However, a single immunopositive
band (17.7 kDa) was prominently visible with equivalent
amounts of CsA column eluate from both total and particulate
extracts (data not shown). Amino-terminal sequencing of these
two immunoreactive bands from either fractions revealed that
their first 12 amino acids, EPEVTAKVYFDV, were identical and
matched with the predicted amino acid sequence (amino acids
22–33) of the cloned LdCyP (Fig. 1). These results unequivocally
proved that (i) the immunopositive protein is indeed the product
of the cloned LdCyP gene and is concentrated mostly in the
particulate fraction of the cell, and (ii) the 21-amino acid NH2-
terminal hydrophobic extension gets cleaved at the computer-
predicted peptide cleavage site.
Level of CsA Binding Activity in Leishmania Promastigotes—
Studies of the cytosolic CyP (CyPA) gene product, both at the
level of transcript and protein, have shown that it is the most
abundant among all the CyP isoforms and constitutes about
75–80% of total CyPs present in almost all cell types studied to
date (9, 22, 23). Despite this, our inability to detect unambig-
uously this isoform of CyP (CyPA) in the cytosol of L. donovani
was puzzling. To investigate whether the failure to detect ap-
preciable signal in the Western blot of the cytosol extract was
at all due to nonreactivity of the polyclonal antisera with other
isoforms of CyPs or the lack of their abundance in the cytosol,
the CyP content in the total cell extract was monitored by two
independent methods and compared. In the first method, the
total extract was subjected to quantitative Western blot anal-
ysis using purified recombinant LdCyP as the standard (Fig. 7),
whereas the second method consisted of direct measurement of
[3H]CsA binding capacity of the extract (Table I). CsA binding
FIG. 7. Quantitation of CyP in total L. donovani promastigote
extract by immunoblot analysis. A, various amounts of CHAPS-
extracted total L. donovani promastigote protein along with known
amounts of recombinant LdCyP were immunoblotted using LdCyP an-
tisera. Autoradiography was performed, and each of the bands was
subjected to phosphoroimaging analysis. Lanes 1–4 contained LdCyP
(80, 40, 20, and 10 ng) as the standard, whereas lanes 5–7 contained 25,
50, and 100 mg of total promastigote protein. B, total counts obtained
under each band shown in A after subtraction from the background
were plotted against the amount of protein loaded on the gel, and CyP
content was determined.
FIG. 5. Analysis of L. donovani CyP transcript(s) by RT-PCR.
Shown are an ethidium bromide-stained agarose gel containing the
PCR products (a) and an autoradiogram of the same gel probed with a
32P-labeled internal reverse oligonucleotide (corresponding to 83FM-
IQGG88) (b). bp, base pair.
FIG. 6. Immunoblot of CyPs from various sources. A, reactivity
of the LdCyP antisera with purified recombinant LdCyP (a), L. dono-
vani total extract (b), purified recombinant P. falciparum cytoplasmic
CyP19 (c), and CsA column eluate of rat liver total extract (d). B,
immunoblot analysis of different subcellular fractions of L. donovani.
Lanes 1–3 (upper and lower panels), total extract (25 mg), particulate
extract (25 mg), cytosol extract (25 mg), respectively; lane 4, purified
recombinant LdCyP (upper panel) and purified recombinant Adk (lower
panel). Upper and lower panels were probed with LdCyP and Adk
antibodies, respectively. C, after two-dimensional gel electrophoresis of
total CHAPS extract, the protein was transferred from the gel to nitro-
cellulose paper and probed with LdCyP antibodies. PAGE, polyacryl-
amide gel electrophoresis.
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capacity by definition would be expected to detect all the high
affinity CyPs. The results obtained by these two methods are in
good agreement and show that LdCyP in the whole cell extract
constitutes about 0.12–0.16% of the total soluble cellular pro-
tein (Fig. 7 and Table I). This correlation is consistent with the
interpretation that (i) LdCyP, associated with the particulate
fraction, is the major constituent of the high affinity CsA bind-
ing proteins present in L. donovani promastigotes, and (ii) the
CsA-binding activity, which normally is known to be most
abundant in the cytoplasm of almost all the cells studied to
date, is conspicuously low in L. donovani promastigotes.
LdCyP Secretion in the Culture Medium—The absence of the
endoplasmic reticulum signal sequence from the matured
LdCyP coupled with its predominant localization in the partic-
ulate fraction of the cell indicated that LdCyP may be one of the
proteins residing in the secretory pathway. Since LdCyP, like
other CyPs, binds CsA with high affinity, these findings led us
to study the fate of the in vivo LdCyP after exposure of the cells
to CsA. The result showed that CsA (2 mM) facilitated the
secretion of the protein into the medium (Fig. 8). With in-
creased time of exposure to CsA, the amount of LdCyP secreted
in the medium gradually increased with its concomitant loss
from the intracellular pool. Adenosine kinase and gp63, known
to be cytosolic and membrane-located enzymes of L. donovani,
could not be detected in the medium with their respective
antisera, confirming that the CsA-induced secretion of LdCyP
in the medium was not due to parasite disintegration or gen-
eralized effect in the presence of CsA (data not shown). Fur-
thermore, the fact that CsA, in combination with sodium azide
(50 mM), failed to release comparable amounts of LdCyP sug-
gests that the cells need to be metabolically active to be able to
secrete LdCyP. The low level of LdCyP released in presence of
sodium azide was possibly due to mechanical lysis of some
parasites during experimental procedure (Fig. 8). A plausible
explanation of these findings could be that CsA mimics the
interaction of LdCyP with some unknown proteins or ligands.
DISCUSSION
The status of CyPs in L. donovani has remained an enigma
ever since it was discovered, that these cells, unlike other
parasitic protozoa, were relatively resistant to CsA. Using de-
generate oligonucleotide, designed against the conserved CsA
binding motif (WLDGRHVVF), a CyP gene (LdCyP) was iso-
lated from the genomic library of the parasite. Although this
result by no means ruled out the absence of other CyP genes in
L. donovani, it prompted us to study the status of CyP proteins
in the free-living form of this parasite. While analyzing the
59-end of the LdCyP-encoded sequence, which distinctly differs
from that reported in L. major, an alternative in-frame ATG
upstream (290 base pair) of the predicted translation initiation
site was detected. However, several features of the DNA se-
quence suggested that this in all probability is not the physio-
logical translation initiation site. This was borne out by the
smaller size of the in vivo protein product. Second, the pre-
dicted translation initiation is preceded by a sequence closer to
the eucaryotic translation initiation signal (39). Third, the oc-
currence of the multiple polypyrimidine stretches, typical of all
the Leishmania-encoded genes, was clearly prevalent up-
stream of the predicted translation initiation site, and finally,
the sequence upstream of the predicted translation site exhibited
only 60% preference for G/C at the wobble position, far lower
than the high G/C bias ($80%) invariably observed in most
genes, including LdCyP, cloned from L. donovani (18, 40, 41).
The most important finding of this work, however, relates to
the levels of expression of CyP proteins in the free-living L.
donovani. Although the RT-PCR amplification studies indicated
the expression of only the cognate LdCyP gene, the combined
results of immunochemical analysis and direct [3H]CsA binding
assays firmly established that LdCyP, associated with the par-
ticulate fraction of the cell, was indeed the most abundant CsA-
binding protein present in the free-living promastigotes. Inter-
estingly, none of these assays detected any appreciable levels of
CsA-binding protein in the cytoplasmic fraction of the cell. Be-
cause gene expression in Leishmania is thought to be predomi-
nantly regulated post-transcriptionally by cis-acting elements
(e.g. by RNA decay and RNA processing and translation), it
remains to be seen whether the lack of abundance of cytosolic
CyP in L. donovani is due to lack of its expression in the promas-
tigote stage or due to other causes like message instability (42).
There is mounting evidence to believe that an appropriate
balance in the intracellular concentrations of CyP or FK506
binding protein and CN play a significant role in determining the
dose-response curves of respective ligand inhibitors, CsA and
FK506 (43, 44). In view of this scenario, the extremely low con-
centration of high affinity CsA-binding protein in the cytosol of
free-living L. donovani promastigotes becomes relevant with re-
gard to CsA resistance of the organism. In the cellular context,
the IC50 of ligand inhibitors is governed not only by intrinsic
affinities but also by effective concentrations of interacting
agents. Therefore, it is most likely that the lack of threshold level
of high affinity cytosolic CsA-binding protein limits the formation
of adequate amounts of intracellular immunophilin-CsA complex
in the cell cytosol simply due to laws of mass action. This allows
cytosol-located CN to carry out its required function, resulting in
relative resistance of the L. donovani promastigotes (45). LdCyP,
located in the particulate fraction of the cell, clearly cannot par-
ticipate in this process. Observations that (i) yeast mutants lack-
ing in CyPA are CsA-resistant but can be made sensitive by the
introduction of the CyPA gene, (ii) the ring-stage form of P.
falciparum, expressing the highest amount of CyP during its
growth cycle, are most susceptible to CsA inhibition, and (iii) the
CsA-resistant human fibroblastic MRC cell line shows low level
TABLE I
Cyclophilin content in total L. donovani extract determined by both
immunoblotting and CsA binding assay
CHAPS-extractable soluble protein was prepared from L. donovani
promastigotes according to the procedure described under “Materials
and Methods.” The dialyzed extract was used for both quantitative
immunoblotting (Fig. 7) and [3H]CsA binding. Assuming 1:1 stoichiom-
etry of binding of CsA to CyP, the CyP content was calculated from the
Sephadex LH-20 column binding assay using an equation described
previously (22, 23). Protein concentration was estimated using Bio-Rad
method.
Fraction Total protein Total CyP content Specificactivity
mg mg mg/mg
Total extract 9.42 Immunoblotting, 11.3 1.2
CsA binding, 14.13 1.5
FIG. 8. CsA-mediated secretion of LdCyP in the medium. After
incubation of L. donovani promastigotes in defined media (with or
without CsA and CsA plus sodium azide), cells and the corresponding
utilized media were collected (”Materials and Methods“) and immuno-
blotted using LdCyP antisera. Lane 1 in both panels represents stand-
ard recombinant LdCyP. Lanes 2–5 (upper panel) contained equal
amounts of protein extracts from cells grown for 0, 6, 10, and 24 h in the
presence of CsA, whereas lanes 2–5 (lower panel) contained equal vol-
umes of the corresponding utilized media. Lanes 6 (upper panel) con-
tained CsA plus sodium azide-treated cell extract (24-h sample),
whereas the lower panel had the corresponding medium. Lane 7, upper
and lower panels, represents 24 h grown normal cell extract and the
corresponding medium, respectively.
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cytosolic cyclophilin support such a contention (46–48). Resist-
ance to FK506 has also been found to be associated with a
deficiency in FK506-binding protein 12 (49). An independent
report published recently further suggests that the low abun-
dance of immunophilins can indeed restrict CN inhibition by CsA
and FK506 in human peripheral blood leukocytes and mouse
spleen cells (50).
The abundance of CsA binding activity in the particulate frac-
tion of the cell raises questions as to the function of LdCyP.
Besides mediating the inhibition of calcineurin phosphatase,
CyPs have been implicated in folding and maturation of proteins
in vivo (7, 8). There can be two ways by which CsA can affect
these molecular processes: either by inhibiting the peptidylprolyl
cis-trans isomerase activity of CyPs or by destabilizing the inter-
action (chaperoning function) of putative proteins with immu-
nophilins. Because the process of protein folding and interactions
among proteins can be either partially or totally prevented by
CsA, it is conceivable that in the absence of these functions, cells
might be more sensitive to conditions that place extra stress on
the capacity of the cell to carry out its growth process (51, 52).
Therefore, the CsA-induced secretion of intracellular LdCyP in
the culture medium leads us to suggest that the drug, because of
its high affinity for LdCyP, probably disrupts the interaction of
LdCyP with some naturally occurring slow-folding protein sub-
strates that under normal conditions help LdCyP to remain an-
chored to the secretory pathway. The fact that LdCyP lacks the
endoplasmic reticulum-anchoring signal sequence (KDEL) and
the concentration of CsA (.7 mM) required to have an inhibitory
effect on L. donovani growth is much higher than the concentra-
tion necessary for inhibition of peptidylprolyl cis-trans isomerase
activity provides support to this proposal. It is likely that at
higher concentrations of CsA, the inhibitory effect of the drug
becomes pronounced, probably due to increased depletion of Ld-
CyP from the intracellular pool. Similar mechanisms have been
proposed while studying the trafficking of human CyPB and
ninaA-rhodopsin interaction in Drosophila (8, 10). However, the
identification of such proteins in L. donovani remains to be
determined.
In summary, we have identified and characterized a noncy-
tosolic high affinity CyP homologue that is predominantly ex-
pressed in free-living L. donovani. Furthermore, the evidence
for extremely low abundance of CsA binding activity in the
cytosol of Leishmania provides an explanation for CsA resist-
ance of the organism. This has opened up a new opportunity to
carry out detailed studies on the physiological function(s) of
this noncytosolic CyP in a cell that is naturally deficient in
cytoplasmic CsA binding activity. Gene knock-out experiments
and identification of physiological partner(s) of LdCyP would
be steps toward understanding such a function(s).
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